Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Reading the Stripes: Is The Industrial Recession Over?

Zebra Technologies' strong earnings and raised guidance signal a turning point for the industrial sector as supply chain hardware spending resumes.

MarketBeat

Eos Energy Enterprises Q1 Earnings Call Highlights

Eos Energy Enterprises (NASDAQ:EOSE) reported a sharp year-over-year increase in first-quarter revenue and outlined a new project financing platform that management said is intended to accelerate adoption of its long-duration energy storage systems. The company generated $57 million in first-quarte

MarketBeat

National Vision Q1 Earnings Call Highlights

National Vision (NASDAQ:EYE) executives said the optical retailer’s first-quarter 2026 results showed progress in its transformation plan, with higher revenue, stronger average ticket and expanded adjusted operating margin, even as management acknowledged pressure from weather, macroeconomic volatil

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Gladstone Investment Q4 Earnings Call Highlights

Gladstone Investment (NASDAQ:GAIN) reported what management described as solid results for its fiscal fourth quarter and year ended March 31, 2026, citing portfolio growth, higher total investment income and a significant increase in net asset value. CEO and President David Dullum said the business

MarketBeat

Eastern Q1 Earnings Call Highlights

Eastern (NASDAQ:EML) reported lower first-quarter fiscal 2026 sales and earnings from continuing operations, as weaker demand for returnable transport packaging and an operating issue at its Big 3 Precision business weighed on margins. Management said improving order trends and sequential backlog gr

MarketBeat

DarioHealth Q1 Earnings Call Highlights

DarioHealth (NASDAQ:DRIO) reported sequential revenue growth for the second straight quarter while outlining plans to expand its digital health platform further into care delivery, management said on the company’s first-quarter 2026 earnings call Wednesday. Chief Executive Officer Erez Raphael said

MarketBeat

CTW Cayman H1 Earnings Call Highlights

CTW Cayman (NASDAQ:CTW) reported nearly flat revenue for the first half of fiscal 2026 while posting a GAAP net loss, as management said new game launches underperformed expectations and mature titles continued to age through their life cycles. On the company’s earnings call for the six months ende

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Micron Investors Face a High-Stakes Moment After the Latest Rally

Micron's May peak is the signal for investors to raise capital in preparation for an upcoming entry point; catalysts include Q3 results scheduled for June.

MarketBeat

How Bad Could Tesla’s Cybertruck Recall Be for Shares?

Tesla’s latest Cybertruck recall looks ugly at first glance, but investors remain far more focused on the company’s expanding AI and autonomy potential.

MarketBeat

Brainsway Q1 Earnings Call Highlights

Brainsway (NASDAQ:BWAY) reported a strong start to 2026, with first-quarter revenue rising 35% year over year as the company expanded placements of its Deep TMS systems and continued to build its recurring revenue base. Chief Executive Officer Hadar Levy said on the company’s earnings call that rev

MarketBeat

Applied Optoelectronics Eyes 800G Ramp as Data Center Demand Tops Capacity Into 2027

Applied Optoelectronics (NASDAQ:AAOI) expects a sharp second-half ramp in its data center optics business as demand for higher-speed transceivers continues to outstrip the company’s manufacturing capacity, Chief Strategy Officer and Chief Financial Officer Dr. Stefan Murry said at Needham’s 21st Ann

MarketBeat

Compass Pathways Q1 Earnings Call Highlights

Compass Pathways (NASDAQ:CMPS) said it has begun a rolling New Drug Application submission for COMP360, its investigational psilocybin treatment for treatment-resistant depression, and is preparing for a potential launch by the end of the year if the therapy is approved. On the company’s first-quar

MarketBeat

Abeona Therapeutics Q1 Earnings Call Highlights

Abeona Therapeutics (NASDAQ:ABEO) reported early commercial momentum for ZEVASKYN in the first quarter of 2026, with executives highlighting new patient treatments, expanded treatment-center activation and a newly licensed prostate cancer cell therapy program during the company’s earnings call. Chi

MarketBeat

Bilfinger Q1 Earnings Call Highlights

Bilfinger (ETR:GBF) confirmed its 2026 outlook after reporting a slower start to the year, with management pointing to severe winter weather and geopolitical uncertainty as factors that delayed customer decisions and pressured operations in the first quarter. Group CEO Thomas Schulz said orders rec

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Merck KGaA Q1 Earnings Call Highlights

Merck KGaA (ETR:MRK) reported what executives described as a “solid start” to 2026, with organic growth in its Life Science and Electronics businesses offsetting a decline in Healthcare, and raised its full-year outlook after stronger momentum late in the quarter. Group Chief Executive Officer Kai

MarketBeat

Altimmune Q1 Earnings Call Highlights

Altimmune (NASDAQ:ALT) said it has strengthened its balance sheet and is preparing to begin a global Phase 3 trial of pemvidutide in metabolic dysfunction-associated steatohepatitis, or MASH, in the second half of 2026, as the company reported first-quarter financial results and provided updates acr

MarketBeat

Brenntag Q1 Earnings Call Highlights

Brenntag (ETR:BNR) said its first-quarter 2026 results reflected a slow start to the year followed by a sharp improvement in March as volatility tied to the crisis in the Middle East lifted pricing and prompted some customers to rebuild inventories. On the company’s earnings call, Chief Operating O

MarketBeat

Humacyte Q1 Earnings Call Highlights

Humacyte (NASDAQ:HUMA) reported first-quarter 2026 Symvess sales of $0.5 million and outlined a series of commercial, clinical and cost-reduction initiatives aimed at accelerating adoption of its bioengineered vascular products. On the company’s earnings call, President and Chief Executive Officer

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Deutsche Telekom Q1 Earnings Call Highlights

Deutsche Telekom (ETR:DTE) reported what Chief Executive Tim Höttges called a “robust” start to 2026, citing broad-based growth across the group and an upgraded full-year outlook following stronger guidance from T-Mobile US. On the company’s first-quarter earnings call, Höttges said group organic s

MarketBeat

RWE Aktiengesellschaft Q1 Earnings Call Highlights

RWE Aktiengesellschaft (ETR:RWE) reported a stronger first quarter for fiscal 2026, with Chief Financial Officer Michael Müller telling analysts that the company had a “good start” to the year and was increasingly confident in meeting its full-year targets. Müller said adjusted EBITDA rose 25% year

MarketBeat

Atour Lifestyle Q1 Earnings Call Highlights

Atour Lifestyle (NASDAQ:ATAT) reported sharply higher first-quarter revenue for 2026, driven by continued expansion of its hotel network and strong growth in its retail business, while management said China’s hotel market is continuing a “moderate recovery” with a shift toward quality and differenti

MarketBeat

MLP Q1 Earnings Call Highlights

MLP (ETR:MLP) reported record first-quarter revenue and earnings for 2026, with Chief Financial Officer Reinhard Loose saying the financial services group remained on its medium-term growth path despite market volatility and macroeconomic uncertainty. On the company’s earnings call, Loose said tota

MarketBeat

Dream Finders Homes’ Hostile Bid Creates a Dual Squeeze Play

Dream Finders Homes is making an aggressive all-cash bid for Beazer Homes, a catalyst that may unlock value and signal further sector consolidation.

MarketBeat

Why OpenAI’s IPO Plans Could Be a Massive Win for Microsoft

Microsoft’s OpenAI investment may now be worth over $228 billion after OpenAI’s restructuring and IPO plans. Here’s what it means for MSFT stock and AI growth.

MarketBeat

A Real Biggie Deal: Wendy's Serves Up a Juicy Buyout Arbitrage

Wendy's is at the center of a potential private equity buyout, with its attractive dividend yield and turnaround plan creating a compelling investment case.

1 … 22 23 24 25

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.